Momenta Pharmaceuticals Inc ( MNTA) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1%. By the end of trading, Momenta Pharmaceuticals Inc rose 37 cents (2.5%) to $15.15 on average volume. Throughout the day, 998,219 shares of Momenta Pharmaceuticals Inc exchanged hands as compared to its average daily volume of 1.2 million shares. The stock ranged in a price between $14.73-$15.25 after having opened the day at $14.76 as compared to the previous trading day's close of $14.78. Other companies within the Health Care sector that increased today were: Cormedix Inc ( CRMD), up 26.5%, Zoll Medical Corporation ( ZOLL), up 22.9%, ProPhase Labs Inc ( PRPH), up 20.3%, and IsoRay Inc ( ISR), up 11%.

Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the characterization and process engineering of complex molecules. These complex molecules include proteins; polypeptides; and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). Momenta Pharmaceuticals Inc has a market cap of $766.1 million and is part of the drugs industry. The company has a P/E ratio of 3.4, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 1.3% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Momenta as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and attractive valuation levels. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.

On the negative front, K-V Pharmaceutical Company ( KV.B), down 19.8%, ARCA biopharma Inc ( ABIO), down 18.1%, World Heart Corporation ( WHRT), down 16%, and D Medical Industries ( DMED), down 12.2%, were all losers within the health care sector with Merck & Co Inc ( MRK) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null